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Porous titanium scaffolds have good mechanical properties that make them an interesting bone 27 
substitute material for large bone defects. These scaffolds can be produced with selective laser 28 
melting, which has the advantage of tailoring the structure’s architecture. Reducing the strut size 29 
reduces the stiffness of the structure and may have a positive effect on bone formation. Two scaffolds 30 
with struts of 120-micron (titanium-120) or 230-micron (titanium-230) were studied in a load-bearing 31 
critical femoral bone defect in rats. The defect was stabilized with an internal plate and treated with 32 
titanium-120, titanium-230, or left empty. In vivo micro-CT scans at four, eight, and twelve weeks 33 
showed more bone in the defects treated with scaffolds. Finally, 18.4±7.1 mm3 (titanium-120, 34 
p=0.015) and 18.7±8.0 mm3 (titanium-230, p=0.012) bone was formed in those defects, significantly 35 
more than in the empty defects (5.8±5.1 mm3). Bending tests on the excised femurs after twelve 36 
weeks showed that the fusion strength reached 62% (titanium-120) and 45% (titanium-230) of the 37 
intact contralateral femurs, but there was no significant difference between the two scaffolds. This 38 
study showed that in addition to adequate mechanical support, porous titanium scaffolds facilitate 39 
bone formation, which results in high mechanical integrity of the treated large bone defects. 40 
Keywords: porous titanium; osteoconduction; bone substitute; bone grafting; micro-CT 41 
1. Introduction 42 
Bone healing requires: 1. cells that are capable of forming bone (osteogenicity), 2. bioactive factors 43 
that can attract such cells and initiate bone formation (osteoinduction), 3. a matrix that guides the bone 44 
formation (osteoconduction), 4. adequate vascularization and 5. initial mechanical support to the 45 
surrounding bone, which becomes more important as the size of the defect increases (1). 46 
Bone defects can be treated with autologous bone. Autologous bone is considered the gold standard 47 
treatment and is mostly harvested from the iliac crest. However, the harvesting procedure has a 48 
complication rate of 10 to 40%, including hemorrhage, nerve, and vascular lesions and post-operative 49 
pain (2). Moreover, the amount and quality of bone that can be harvested is limited, restricting its use 50 
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in large defects (3). Therefore, large bone defects are currently treated by distraction osteogenesis, 51 
vascularized bone (fibula) grafting, or massive cortical allografts (4). All treatments have their specific 52 
disadvantages, such as multiple surgical procedures, high complication rates, and prolonged periods of 53 
immobility and rehabilitation. 54 
The challenge is to develop a bone substitute material that enhances bone healing but also offers 55 
adequate mechanical strength. Porous titanium scaffolds are especially interesting, since titanium has 56 
superior mechanical properties compared to other synthetic materials such as calcium phosphate 57 
ceramics and polymers (5). Although the potential of porous titanium has been recognized for many 58 
years, development of open porous structures has been hampered by the limitations of available 59 
production techniques (6). With production techniques such as plasma spraying (7), space-holder 60 
techniques (8), powder metallurgy (9), or sintering of titanium fibers (10) it remains difficult to 61 
produce a porous structure with the desired architecture that meets both osteoconductive and 62 
mechanical requirements. For osteoconduction, an open interconnected porous structure with pores in 63 
the range of 200-500 µm is required (11). From a mechanical point of view, the structure should be 64 
stiff enough to sustain the physiological loads, but it should not drastically exceed the stiffness of the 65 
bone being replaced to avoid stress shielding. 66 
Better control over the structural architecture can be acquired using selective laser melting (SLM) 67 
(12). SLM allows production of very fine and small porous titanium structures, with struts in the range 68 
of 100-200 µm. This enables the possibility of tailoring and optimizing the structural and mechanical 69 
properties of the scaffolds while maintaining the required pore dimensions that allow for bone and 70 
vessel ingrowth. Thinner titanium struts may result in increased elastic and plastic deformation. Such 71 
deformation of the porous structure reduces stress-shielding inside the scaffold and may provide a 72 
biomechanical stimulus for the bone-forming cells, thereby resulting in more bone formation (13). 73 
In this study, we used a critically sized femoral bone defect in a rat model to test two hypotheses: 1. 74 
porous titanium scaffolds can be a biomechanically strong osteoconductive scaffold for repair of 75 
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cortical bone defects, 2. thinner strut sizes will result in favorable mechanical properties that will 76 
increase bone formation within the titanium scaffold thereby improving mechanical integrity of the 77 
treated bone defect. 78 
2. Materials and methods 79 
2.1. Porous titanium scaffolds 80 
Porous titanium scaffolds were produced from Ti6Al4V using SLM (Layerwise, Belgium). Two 81 
structural variants were designed using a dodecahedron unit cell as a template structure. One variant 82 
consisted of thin titanium struts (‘titanium-120’) and the second variant consisted of thick titanium 83 
struts (‘titanium-230’). Both structural variants were produced in two different shapes: 1. cylindrical 84 
scaffolds (5 mm Ø x 10 mm) for determining the compression strength and the Young’s modulus 85 
(supplementary material 1) and 2. femur-shaped scaffolds (6 mm mid-diaphyseal segment of the 86 
femur bone, Fig. 1) for determining the ultimate compression force (UCF) (supplementary material 1) 87 
and for in vivo implantation. All samples underwent post-production chemical and heat treatment to 88 
increase surface roughness (supplementary material 2). 89 
2.2. Animal experiment 90 
In 27 male Wistar rats, a 6 mm segmental bone defect of the right femur was created and treated with 91 
either titanium-120 (n = 9) or titanium-230 (n = 9) or, was left empty in the control group (n = 9). The 92 
local animal ethics committee approved the study. All animals were housed according to the national 93 
guidelines for care and use of laboratory animals. 94 
2.2.1 Surgical procedure 95 
A single dose of antibiotics (enrofloxacin, 5 mg/kg body weight) was administered one hour before 96 
surgery. The operation was performed aseptically under general anesthesia (1-3.5% isoflurane). The 97 
right femur was exposed though a lateral incision of the skin and division of the underlying fascia. A 98 
23 mm long PEEK plate (RatFix, AO Foundation, Switzerland) was fixated to the anterolateral plane 99 
of the femur. Three proximal and three distal screws fixated the plate. The periostium was removed 100 
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over approximately 8 mm of the mid-diaphysial region before removal of the 6 mm long bone 101 
segment. The bone segment was removed with a tailor-made saw guide and a wire saw (RatFix, AO 102 
Foundation, Switzerland), and the scaffold was placed press-fit into the defect site. The fascia and skin 103 
were sutured in layers and prophylactic pain medication (buprenorphine, 0.05 mg/kg body weight) 104 
was administered twice a day for the first three days after surgery. Fluorescent dyes were administered 105 
at four (tetracyclin, 25 mg/kg body weight), eight (calcein, 25 mg/kg body weight), and eleven weeks 106 
(xylenol orange, 90 mg/kg body weight). 107 
2.2.2. Micro-CT evaluation 108 
Immediately after the surgery, while the rats were still under general anesthesia, a SkyScan 1076 109 
scanner (Bruker micro-CT, Belgium) was used in order to acquire a baseline in vivo micro-CT scan. A 110 
36 µm-resolution protocol was used at 95 kV, 1.0 mm Al filter, and 0.6 degree rotation step, resulting 111 
in a 15 minute scan. In vivo scans were repeated after four, eight, and twelve weeks. For the final ex 112 
vivo scan, an 18 µm-resolution protocol was used at 95 kV, 1.0 mm Al/0.25 mm Cu filter, and 0.4 113 
degree rotation step (3 h scan). The CT images were reconstructed using volumetric reconstruction 114 
software NRecon version 1.5 (Bruker micro-CT, Belgium). 115 
The total bone volume (TBV) was defined as the total bone volume within the 6 mm defect segment 116 
including bone formed around the titanium scaffold (Fig. 2A) The bone volume in pores (BVp) was 117 
defined as the bone volume measured within the pore volume (PV) of the titanium scaffold (Fig. 2B), 118 
and is also expressed as a percentage of the pore volume (BVp/PV). TBV and BVp were determined 119 
using software CTAnalyser version 1.11 (Bruker micro-CT, Belgium) (supplementary material 3). 120 
2.2.3. Biomechanical evaluation 121 
The final strength of the treated femurs was measured with three-point bending tests conducted on five 122 
samples from each group. In these tests, both supports are chosen as close as possible to the bone-123 
scaffold interfaces (distance < 5 mm). Small distance between the bone-scaffold interfaces and the 124 
supports ensures that the three-point bending test measures the interface strength of bone and scaffold 125 
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as closely as possible. The contralateral femurs served as controls. To ensure that we tested the entire 126 
spectrum, we first sorted the treated femurs according to their BVp and then included every other 127 
femur. The bending tests were carried out using a Zwick test machine (Zwick GmbH, Germany) as 128 
follows: first, the PEEK plate was carefully removed; the femurs were then supported at the proximal 129 
and distal side using two plates that were secured with screws. A plate that exceeded the average 130 
pore size applied a downward force to the middle of the porous titanium scaffold, pushing it outside 131 
the bone defect. The bending tests were performed at a displacement rate of 2 mm/min until the peak 132 
load was reached. The force-displacement curves were recorded and used to determine the maximum 133 
force. 134 
2.2.4. Histological evaluation 135 
Histology was performed on four femurs of each group to study the bone-titanium interface and bone 136 
morphology. The specimens were dehydrated in a graded ethanol series, and embedded in 137 
methylmethacrylate. Sections of ~20 µm were obtained using a diamond saw (Leica SP1600) and 138 
stained with basic fuchsin 0.3% solution (Sigma) and methylene blue 1% solution (Sigma). Bone 139 
stains red with basic fuchsin and fibrous tissue stains blue with methylene blue. Unstained sections 140 
were examined using an epifluorescent microscope (Axiovert 200MOT/Carl Zeiss) with a triple filter 141 
block. 142 
2.3. Statistics 143 
Statistical analyses were performed using SPSS Statistics 17.0 (SPSS Inc, Chicago, Ill). The data are 144 
presented as means with standard deviation. One-way Analysis of Variation (ANOVA) and 145 
subsequent post-hoc pairwise comparisons with Bonferroni adjustment was used to analyze the 146 
differences between the three groups. A repeated measures general linear model was used when 147 
examining the longitudinal in vivo micro-CT data. A Pearsons correlation coefficient was used to 148 
determine the correlation between BVp, TBV, and the maximum bending force. 149 
3. Results 150 
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3.1. Porous titanium scaffolds 151 
The different titanium strut sizes and equal pore dimensions resulted in a porosity of 88% in the 152 
titanium-120 scaffolds and 68% in the titanium-230 scaffolds (Table 1). The titanium-120 structure 153 
had five-fold lower compression strength and a four-fold lower homogenized Young’s modulus than 154 
the titanium-230 structure (Table 1). There was a significant difference in the UCF (p<0.001). The 155 
UCF of the titanium-230 scaffolds (530±85 N) was higher than the corresponding bone segments 156 
(441±31 N, p=0.022), whereas the UCF of titanium-120 scaffolds (84±11 N) was lower than the 157 
corresponding bone segments (p<0.001) (Fig. 3). 158 
3.2. Micro-CT evaluation 159 
Correct positioning of the porous titanium scaffolds was confirmed by micro-CT directly after surgery 160 
in all animals and no dislocation of the porous titanium scaffolds was detected during the follow-up. 161 
The titanium-230 structure remained completely intact in all rats, whereas breakage of some struts was 162 
seen in six of the nine rats given titanium-120. This occurred after either four (two cases) or eight 163 
weeks (four cases), but did not result in loss of fixation or complete loss of structural integrity of the 164 
scaffolds. The porous titanium scaffolds were well integrated with the adjacent cortical bone and a 165 
progression of the bony bridging was observed over time (Fig. S1), although in some rats small areas 166 
of the adjacent cortical underwent changes that may indicate bone resorption (Fig. S2). In the empty 167 
control group, loss of fixation, due to breakage of the screws, occurred in six out of nine rats. This 168 
happened to one rat at four weeks, to four rats at eight weeks, and to one rat at twelve weeks. Those 169 
rats were taken out of the experiment at subsequent time points. In the remaining rats, no bridging of 170 
the defect had occurred and a consistent pattern of bone resorption of the remaining cortical bone was 171 
observed (Fig. S3). 172 
Treatment with porous titanium scaffolds resulted in more TBV than in the empty controls at 173 
all time points (Fig. 4A). The increase of TBV was most profound between four and twelve weeks, 174 
whereas in the empty controls TBV seemed to have reached a plateau phase after eight weeks. At 175 
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twelve weeks, a significant difference in the TBV (p=0.008) was found (Fig 4B). The TBV of the 176 
titanium-120 group (18.4±7.1 mm3) and the titanium-230 group (18.7±8.0 mm3) was significantly 177 
higher than in TBV of the empty control group (5.8±5.1 mm3, p=0.015 and p=0.012 respectively). 178 
The porous structure of the titanium scaffolds facilitated bone ingrowth given that an increase 179 
of BVp was found at all time points (Fig 5A). At twelve weeks, the absolute BVp was 7.4±2.3 mm3 in 180 
the titanium-120 scaffolds and 6.0±2.7 mm3 in the titanium-230 scaffolds (p=0.38) (Fig. 5B). This 181 
resulted in a BVp/PV of 16±5 % in the titanium-120 and 20±9 % in the titanium-230. 182 
3.3. Biomechanical evaluation 183 
The intact femurs that served as control broke at a force of 233±27N. The bending force of the 184 
titanium-120-treated femurs was 144±73N (62% of control) compared with 104±38N (45% of 185 
control) for titanium-230-treated femurs (Fig. 6A). Except for one case, all samples broke at the 186 
titanium-bone interface. BVp measured with micro-CT strongly correlated with the maximum 187 
bending force for the titanium-120 group (r2=0.83, p=0.03). The two treated femurs in which more 188 
than 8 mm3 bone had formed within the pores had a bending force comparable with the intact control 189 
femurs (Fig. 6B). For the titanium-230 group, the maximum bending force did not seem to relate to 190 
BVp (r2=0.02, p=0.84). 191 
3.4. Histological evaluation 192 
In the histological evaluation, the empty defect sites showed limited bone formation and 193 
resorption of the cortical bone at the proximal and distal sites (Fig. 7A and F). Within the remaining 194 
defect area, abundant fibrous tissue was found. 195 
Histology of the titanium groups revealed formation of a major plug of new bone in the 196 
medullary canal at both ends of the bone defect. This bone is most likely formed through the process 197 
of direct ossification (Fig. 7B and D). The newly formed bone extents from this plug into the porous 198 
titanium and the inner space of the scaffold. Bone was also abundant at the outer area of the scaffolds, 199 
showing signs of an attempt to bridge the defect area. The area inside the porous titanium that was not 200 
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filled with bone was filled with fibrous tissue. The pattern observed correlated well with the bone seen 201 
on the corresponding micro-CT images (Fig. 7G and H). 202 
Bone is directly formed on the surface of the porous titanium scaffold. At some areas, 203 
however, a thin layer of fibrous tissue between the titanium and the bone was observed (Fig. 7E). No 204 
signs of foreign body reactions or inflammation were detected. In one titanium-120 sample, a possible 205 
development of a hypertrophic non-union was seen, since a cluster of chondrocytes was found at a site 206 
suspect to breakage of titanium struts (Fig. 7C). 207 
The injected fluorochrome labels showed the mineralized bone at four (red), eight (green) and 208 
twelve weeks (yellow) (Fig. 8). The observed pattern of fluorochrome labels indicate that bone 209 
formation was most active around the titanium-bone interface at the proximal and distal ends of the 210 
porous titanium scaffolds (Fig. 8D). Only limited progression of the bridging of the bone defect 211 
through the medullary cannel was seen between the four and twelve weeks (Fig. 8C), since the label 212 
injected at four weeks (red) was found close to the most advanced bone fronts (yellow). 213 
4. Discussion 214 
This longitudinal in vivo study supports our first hypothesis that porous titanium scaffolds provide 215 
mechanical support in the early phase after implantation, and facilitate bone formation 216 
(osteoconduction) over time, resulting in good mechanical strength of the treated femurs after twelve 217 
weeks. A lower titanium strut size reduced the homogenized Young’s modulus of the scaffold but did 218 
not result in significantly more bone formation or higher mechanical strength of the treated femurs, 219 
meaning that these experiments did not support our second hypothesis. 220 
The osteoconductive properties of porous titanium scaffolds were proven by the fact that more 221 
bone had formed in the bone defects treated than in the defects that were left empty. This is in line 222 
with previous reports that used a metaphyseal bone defect model in rabbits (14; 21-24). The rat femur 223 
bone defect model used here has the advantage that it allows for in vivo micro-CT scanning to monitor 224 
bone formation throughout time. Bone formation was measured using a custom-made algorithm that 225 
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first removed the metal artifacts and then selected the areas of newly formed bone (supplementary 226 
material 3). Accurate selection of bone was verified using the corresponding histological sections as a 227 
reference (Fig. 7). The in vivo bone measurements showed a gradual increase in bone formation in the 228 
rats that received titanium-120 or titanium-230 scaffolds, this bone formation may have still been 229 
ongoing, because no plateau phase was reached within the twelve weeks follow-up period (Fig 4A). 230 
The increase in bone regeneration seen in the defects treated with porous titanium scaffolds 231 
may be related to the scaffold structure and its mechanical properties. The structure of osteoconductive 232 
scaffolds is well defined in terms of pore size, interconnectivity, and porosity (11) and these criteria 233 
were met for both structural variants. However, the mechanical properties of the two structural 234 
variants were different due to their different strut sizes. Reducing the strut size by ~50% in the 235 
titanium-120 structure resulted in a large decrease of the homogenized Young’s modulus (Table 1). 236 
The measured homogenized Young’s modulus for the titanium-120 is close to the lowest range 237 
reported in the literature for porous titanium (8; 14-17) and within the range of human trabecular bone 238 
(0.01-2 GPa) (18). Such low homogenized Young’s modulus allows for more deformation upon 239 
loading, and was therefore hypothesized to result in more bone ingrowth in the titanium-120 scaffolds. 240 
However, there was not significantly more bone formed after twelve weeks (Fig 5B) and a possible 241 
explanation could be that the loads that were applied to the titanium-120 scaffolds after implantation in 242 
the femoral bone defect were not able to reach the minimum force required to deform the scaffolds. 243 
Defining the mechanical properties that would have allowed deformation of the porous 244 
titanium scaffolds after implantation was complicated by a number of factors. Although the titanium-245 
120 was significantly weaker than the femur segment that it replaced and the titanium-230 was 246 
significantly stronger in term of UCF, however bone is able to withstand forces that are at least twice 247 
the normal peak loading (19). Furthermore, different bones and even different areas of a bone can 248 
have different mechanical properties (18). Finally, not all the mechanical loads will be transferred 249 
through the porous titanium scaffolds, since a portion of the load will be transferred to the PEEK 250 
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fixation plate. Preliminary results of a finite element model of this femur bone defect indicates that the 251 
division of force is highly dependent on the stiffness of the scaffold, the contact conditions between 252 
the scaffold and bone, and the mechanical loading (20). Moreover, the load distribution changes over 253 
time as more bone is generated within the scaffold. Taking into account all these factors to define the 254 
optimal mechanical properties of porous titanium scaffolds remains difficult. One should therefore 255 
take the species, the type of bone that needs to be replaced, and the applied fixation methods into 256 
account. 257 
Implantation of the titanium scaffolds provided sufficient support to the bone defect, because it 258 
did not result in a loss of fixation, whereas in most rats for which the defect was left empty the PEEK 259 
plate fixation failed. The ability to provide sufficient support is likely to have contributed to the bone 260 
formation in the defect area but is only made possible by the mechanical properties that allow the 261 
porous titanium scaffold to function as a load-bearing scaffold in this rat femur defect. The final 262 
strength of the treated femurs was measured using three-point bending test. In the three-point bending 263 
test, the supports were chosen very close to the bone-scaffold interface, so that the bending test more 264 
or less measures the interface strength between bones and scaffold and is therefore somewhat similar 265 
to torsion test. The bending forces are surprisingly high, taking into account twelve weeks 266 
implantation period and that only about 20% of the pore volume was occupied by newly formed bone. 267 
The broken struts seen in the titanium-120 scaffolds, which itself could be explained by the limited 268 
compression strength, did not have a negative impact on the maximum bending force. In fact, the 269 
maximum bending force was even somewhat higher in the titanium-120 group compared to the 270 
titanium-230 group (Fig 6A). Interestingly, there is a strong correlation between the bending force and 271 
the bone volume inside the pores for the titanium-120 scaffolds but not for titanium-230. Possible 272 
factors other than bone volume that may affect the strength of the treated femurs could be the bone-273 
titanium bonding. Previous studies that used similar heat and surface treatments showed good bone-274 
bonding and even indicated a possible osteoinductive role of the modified surface (25). The larger 275 
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surface area in the titanium-120 scaffolds (Table 1) may have resulted in a larger area of direct bone-276 
titanium contact. This may explain why bone volume within the pores shows a better correlation with 277 
the final mechanical strength for the femurs that received a titanium-120 scaffold than those that 278 
received titanium-230. 279 
The work presented here shows the potential of porous titanium scaffolds, and especially the 280 
possibility to function as a load-bearing scaffold may become relevant in clinical cases where 281 
conventional fixation methods alone may be insufficient. But before porous titanium can be used in 282 
clinical cases, the mechanical properties should be tailored to the human situation. Another aspect of 283 
porous titanium that should be further explored is the surface. Surface modifications have been studied 284 
by others (26), and it presents a great opportunity to enhance bone-titanium bonding or increase bone 285 
formation. A possible example would be the addition of a calcium phosphate coating (27). The surface 286 
may also be used to address the main drawback of titanium implants, i.e. the risk of infection. 287 
Antibiotic coatings have already been developed for solid implants (28), and they may help to reduce 288 
the risk of infection. The challenge will be to combine all these different techniques into one porous 289 
titanium scaffold that can withstand thorough experimental testing before proceeding to clinical trials. 290 
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Table 1: Structural and mechanical characteristics of porous titanium scaffolds 373 
 374 
 Titanium-120 Titanium-230 Cortical bone (rat) 
Porosity (%) 88 68  
Titanium thickness (µm) 120 230  
Pore size (µm) 490 (240-730) 490 (240-730)  
Surface area / volume (µm2) 0.034 0.018  
Compression strength (MPa) 14.3±1.7 77.7±12.8 140±19 (29) 
Homogenized Young’s 
modulus (GPa) 
0.38±0.04 1.56±0.21 8.80±2.53 (29) 
Pore size is presented as median and range. Compression strength and homogenized Young’s 375 
modulus is presented as average + SD. 376 
377 
 16 
Figure legends 378 
Figure 1: Femur-shaped porous titanium scaffolds  379 
 380 
Titanium-120 structure (A) and titanium-230 structure (B). Bar indicates 1 mm. 381 
382 
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Figure 2: CT measurements  383 
 384 
Transversal micro-CT image with volume of interest (blue) used for measurements of TBV (A) and 385 
BVp (B). Bar indicates 1 mm. 386 
387 
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Figure 3: Ultimate compression force of titanium-120, titanium-230, and cortical bone 388 
 389 
Statistical analysis was performed with One-Way analysis of Variance (ANOVA) subsequent post-390 
hoc pairwise with Bonferroni adjustment, * is p<0.05. 391 
392 
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Figure 4: Total bone volume  393 
 394 
Total bone volume (TBV) measured in vivo during the study period (A) and ex vivo at twelve weeks 395 
(B). The in vivo measurements were corrected for artifacts using the scan made at time point zero. 396 
Statistical analysis was performed with One-Way analysis of Variance (ANOVA) subsequent post-397 
hoc pairwise with Bonferroni adjustment, * is p<0.05. 398 
399 
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Figure 5: Bone volume in pores 400 
 401 
Bone volume in pores (BVp) measured in vivo during the study period (A) and ex vivo at twelve 402 
weeks (B). The in vivo measurements were corrected for artifacts using the scan made at time point 403 
zero. Statistical analysis was performed with One-Way analysis of Variance (ANOVA), NS is not 404 
statistically significant. 405 
406 
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Figure 6: Biomechanical bending test  407 
 408 
Average maximum bending force (A) and bending force correlated to bone in pore volume (B). 409 
410 
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Figure 7: Histology and micro-CT  411 
 412 
Histological slides with corresponding micro-CT images of an empty defect (A and F), titanium-120 413 
(B and G) and titanium-230 (D and H), including detailed interface view for titanium-120 (C) and 414 
titanium-230 (E). Black bar indicates 1 mm. 415 
416 
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Figure 8: Fluorochrome labeling  417 
 418 
Light microscopy images of the fluorochrome labels of a femur treated with titanium-120 (A) 419 
including corresponding histological (B) and micro-CT (C) images. The asterisks indicate active 420 
mineralization at the titanium-bone interface, white arrows indicate limited activity at the bone fronts 421 
in the medullary canal. Tetracyclin label (4 weeks) is red, calcein label (8 weeks) is green and xylenol 422 
orange label (12 weeks) is yellow. Bars indicate 1 mm. 423 
424 
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Supplemental material 425 
 426 
Figure 1 Defect bridging 427 
 428 
 429 
Figure 2 Resorption 430 
 431 
 25 
Figure 3 Empty defect 432 
 433 
 434 
Figure 4 SEM image 435 
 436 
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